Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765099 · ClinicalTrials.gov registry record · NA
Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03765099: Completed NA study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT03765099 is a NA study that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03765099, a NA study, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will evaluate the effects of animal-assisted interactions (AAI) on stress, anxiety, and quality of life in children with a life-threatening condition and their parents. It is anticipated to be a milestone in understanding the human-animal bond.
Primary Outcome
The Peds Quality of Life measure will be administered to children and their parents (proxy) once a month
Interventions
- BEHAVIORAL Animal-Assisted Interactions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-02-21 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT03765099 record still lists
NCT03765099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Animal-Assisted Interactions is the first listed.
NCT03765099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03765099 about?
NCT03765099 is a clinical study titled "Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents". This study will evaluate the effects of animal-assisted interactions (AAI) on stress, anxiety, and quality of life in children with a life-threatening condition and their parents. It is anticipated to be a milestone in understanding the human-animal bond.
What is the current status of trial NCT03765099?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2019-02-21. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03765099?
The interventions under investigation include: Animal-Assisted Interactions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03765099?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03765099's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI